These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17869664)

  • 1. Correlation of traditional point a with anatomic location of uterine artery and ureter in cancer of the uterine cervix.
    Wang KL; Yang YC; Chao KS; Wu MH; Tai HC; Chen TC; Huang MC; Chen JR; Su TH; Chen YJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):498-503. PubMed ID: 17869664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.
    Datta NR; Srivastava A; Maria Das KJ; Gupta A; Rastogi N
    Brachytherapy; 2006; 5(4):223-9. PubMed ID: 17118314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder dose estimation during intracavitary brachytherapy for carcinoma of the cervix using a single line source system.
    Tan LT; Warren J; Freestone G; Jones B
    Br J Radiol; 1996 Oct; 69(826):953-62. PubMed ID: 9038532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
    Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
    J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
    Lewocki M
    Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix.
    Corn BW; Hanlon AL; Pajak TF; Owen J; Hanks GE
    Gynecol Oncol; 1994 Jun; 53(3):294-300. PubMed ID: 8206401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix: frequency and types of variation.
    Kim RY; Meyer JT; Plott WE; Spencer SA; Meredith RF; Jennelle RL; Salter MM
    Radiology; 1995 May; 195(2):419-22. PubMed ID: 7724760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
    Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.
    Lin LL; Mutic S; Malyapa RS; Low DA; Miller TR; Vicic M; Laforest R; Zoberi I; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1494-501. PubMed ID: 16154713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing radiation dose to pelvic small bowel in cervical cancer patients treated with Ir-192 intracavitary brachytherapy by using urinary bladder distension.
    Sukhaboon J; Shotelersuk K; Lertsanguansinchai P; Khorprasert C
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S200-6. PubMed ID: 16623029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.